Company Profile
BioNano Genomics Stock Price, News & Analysis
- Ticker:
- BNGO
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- United States
Stock performance
1.17 USD (-2.50%)
Close
Last updated: July 13, 2026 at 00:00
13.77M USD
Market cap
Why the stock is moving
BNGO is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
BioNano Genomics is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, BioNano Genomics is followed within the diagnostics and tools universe for its exposure to customer demand and adoption cycles.
Business Model Characteristics
BioNano Genomics is a commercial-tools story where install base, recurring demand, and product adoption drive the narrative more than one-off clinical events.
Position Within the Biotechnology Landscape
Compared with therapeutic biotech names, BioNano Genomics sits on a different part of the landscape where utilization, customer demand, and product refresh tend to matter more than binary FDA events.
Future catalysts
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
Zimmer Biomet Names Chintan Desai President of Asia Pacific Region
ZBH · Source: Zimmer Biomet
- 02
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results
ZBH · Source: Zimmer Biomet
- 03
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma
BMY · Source: BMYBristol-Myers Squibb Company
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of BioNano Genomics (BNGO)?
BioNano Genomics (BNGO) most recently closed at 1.17 USD, a -2.50% move versus the previous session.
What is the market cap of BioNano Genomics (BNGO)?
BioNano Genomics currently has a market capitalization of 13.77M USD on BioPharmSignal.
What does BioNano Genomics do?
BioNano Genomics is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.
On which exchange is BNGO stock listed?
BioNano Genomics (BNGO) is associated with NASDAQ, United States, Biotechnology.
What is BioNano?
BioNano Genomics is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.
Which conditions is BioNano Genomics targeting with BioNano?
BioNano Genomics is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.
What is Genomics?
BioNano Genomics is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.